Some antibodies neutralize the virus effectively, while others bind only weakly. Pinpointing exactly which parts of a virus ...

A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just ...

Researchers map pathways to protective antibodies for an HIV vaccine. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2017 / 03 / 170315143838.htm ...

A research team has turned the bodies of dead mice into vivid 3D maps of anatomy, with tissues, nerves, and vessels highlighted in color. The technique, which renders the corpses transparent and then ...

Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive ...

The phase 2b study lays out a path toward developing monoclonal antibody drugs for passive prevention of HIV. ... Monoclonal Antibodies Prevent HIV in Proof-of-Concept Trial - Medscape - Mar 17, 2021.

In a recent study, Furukawa and colleagues map how antibodies from three patients bind to NMDARs. The study is published in the journal Nature Structural & Molecular Biology.

MADISON, Wis.--(BUSINESS WIRE)--Invenra Inc., a pioneer in multispecific antibody discovery and development, announces the launch of its T-Body™ trispecific antibody platform, a next-generation ...

Scientists in South Africa have mapped the evolution of an antibody that kills different strains of the HIV virus, which might yield a vaccine for the incurable disease, the National Institute of ...

Long-lasting in vivo antibody production: DMAb levels remained stable for 72 weeks in all participants (n=24) who have reached that timepoint No anti-drug antibodies (ADA): no immune rejection of ...

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19 Mar. 13, 2025 6:15 PM ET Inovio Pharmaceuticals ...